HBK Investments’s Omnicell OMCL Stock Holding History

HBK Investments’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-45,200	Closed	-$3.38M	–	745
2020 Q3	$3.38M	Buy	+45,200	New	+$3.13M	0.03%	288

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HBK Investments's OMCL Position: Q4 2020 in Review

HBK Investments sold out of Omnicell (OMCL) in Q4 2020, closing a stake of 45,200 shares — an estimated $3.38M sold.

HBK Investments first reported a position in OMCL in Q3 2020 and held it in 1 quarter. The position peaked at $3.38M in Q3 2020. 354 funds tracked by Wall St. Rank hold OMCL as of Q4 2020.

HBK Investments reported no remaining Omnicell position as of Q4 2020 after selling out during the quarter.
HBK Investments sold 45,200 Omnicell shares in Q4 2020, an estimated $3.38M.
HBK Investments first reported a position in Omnicell in Q3 2020 and held it in 1 quarter.
HBK Investments's Omnicell position peaked at $3.38M in Q3 2020.
354 funds tracked by Wall St. Rank held Omnicell as of Q4 2020.

Based on HBK Investments's 13F filing for Q4 2020, filed 16 Feb 2021.